Immunotherapy following high-dose chemotherapy (HDCT) and peripheral blood progenitor cell transplantation (PBPCT) in the treatment of high-risk early breast cancer (HREBC) and metastatic breast cancer (MBC).

Author(s):  
F Recchia ◽  
G Candeloro ◽  
S Necozione ◽  
M Sureda ◽  
A Brugarolas ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document